Disclosed is a process for the manufacture of pancreatin in which the concentration of one or more biological contaminants is reduced, such as viruses and/or bacteria, said process comprising heating the pancreatin at a temperature of at least 85 °C at a total solvents content of less than 9% by weight. Further disclosed is a pancreatin obtainable by such a process.